SART3

Spliceosome associated factor 3, U4/U6 recycling protein · Q15020 · SART3 on Sugi Atlas →

0 patent compounds predicted against SART3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SART3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study nanUNKNOWN
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients nanACTIVE_NOT_RECRUITING
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Prognosis of METTL-14 in Endometrial Carcinoma nanNOT_YET_RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Quantification of GADD34 Expression in RA nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
BAFF Levels and Lupus Nephritis (LN) nanWITHDRAWN
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study nanACTIVE_NOT_RECRUITING
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SART3 binder may also engage these)

ProteinNameSimilarity
Q5REG1 1.000 Q5REG1 →
Q9JLI8 0.999 Q9JLI8 →
B3DJT0 0.995 B3DJT0 →
A1XD93 0.986 A1XD93 →
O74970 0.985 O74970 →
C0HAV3 0.985 C0HAV3 →
Q1JPZ7 0.984 Q1JPZ7 →
Q15326 0.984 Q15326 →
Q9YHB5 0.983 Q9YHB5 →
Q0IIX9 0.983 Q0IIX9 →
Q4KLU2 0.983 Q4KLU2 →
Q9ERA6 0.983 Q9ERA6 →
Q2KJJ0 0.983 Q2KJJ0 →
Q7SXW2 0.983 Q7SXW2 →
A4UMC5 0.982 A4UMC5 →
Q32PZ3 0.982 Q32PZ3 →
U2SURP U2 snRNP-associated SURP motif-containing protein 0.982 landscape →
Q64378 0.982 Q64378 →
Q7SAK5 0.982 Q7SAK5 →
Q86UA1 0.982 Q86UA1 →
Q5U2Y6 0.982 Q5U2Y6 →
Q29RR5 0.981 Q29RR5 →
Q8K2Z2 0.981 Q8K2Z2 →
Q6ES52 0.981 Q6ES52 →
Q6DEY1 0.981 Q6DEY1 →
A1XD94 0.981 A1XD94 →
Q9LZZ7 0.981 Q9LZZ7 →
Q5R5K8 0.981 Q5R5K8 →
O54774 0.981 O54774 →
A1XD95 0.981 A1XD95 →